A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

Clinical trial NCT06769659 · RECRUITING

Trial details

NCT number: NCT06769659
Sponsor: NeuroPro Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epilepsy, Generalized Epilepsy, Absence

Start date: 2025-03-11
Primary completion: 2026-08-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.